New compound discovered as a result of continued focus on topoisomerase inhibitors at Xenova Nov. 2, 2001
Orally active KDR tyrosine kinase inhibitor effective in spontaneously metastatic human tumor model Oct. 31, 2001
Positive interaction demonstrated between PI-88 and several cytotoxic agents in animal tumor model Oct. 31, 2001
Inex c-myc antisense oligonucleotide well tolerated in phase I study in combination with cisplatin Oct. 31, 2001
RSS